PCK 5.56% 3.4¢ painchek ltd

Studies by RAP have a weak efficacy for a medial diagnostic...

  1. 330 Posts.
    lightbulb Created with Sketch. 57
    Studies by RAP have a weak efficacy for a medial diagnostic tool. The associated liability with a misdiagnosis is far too high. Neither the patient or the physician will truly trust the app. I had a clinical specialist review RAP's clinical trail results - his response was 'meh'. No hard evidence and a bit of pseudo science saying that you can diagnose something from the sound of a cough.

    Good luck.
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.